SCHEMBL16827356

SCHEMBL16827356

COc1ccc2c(c1)CCN(c1ccc(CC(C)C)c(C)c1)C2=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 7/20 0.45
▸ PRMT5 O14744 1/20 0.39
▸ WDR77 Q9BQA1 1/20 0.39
▸ CYP26A1 O43174 2/20 0.39
▸ CYP24A1 Q07973 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ PDE4A P27815 1/20 0.38
▸ PDE4B Q07343 1/20 0.38
▸ PDE4C Q08493 1/20 0.38
▸ PDE4D Q08499 1/20 0.38
▸ SRD5A1 P18405 1/20 0.38
▸ GAA P10253 1/20 0.37
▸ DRD2 P14416 1/20 0.37
▸ DRD1 P21728 1/20 0.37
▸ DRD4 P21917 1/20 0.37
▸ NR1H4 Q96RI1 1/20 0.37
▸ S1PR1 P21453 1/20 0.36
▸ S1PR3 Q99500 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16827555 0.84 AOC3 (0.48) AOC3PRMT5WDR77CYP26A1CYP24A1
SCHEMBL16848251 0.82 AOC3 (0.43) AOC3PRMT5WDR77CYP26A1NPC1
SCHEMBL16827429 0.81 AOC3 (0.48) AOC3PRMT5WDR77CYP26A1NPC1
SCHEMBL16827522 0.81 AOC3 (0.41) AOC3PRMT5WDR77NPC1PKM
SCHEMBL16848202 0.79 AOC3 (0.61) AOC3NPC1PKMRAB9APDE4A
SCHEMBL16848248 0.79 AOC3 (0.48) AOC3NPC1PKMRAB9APDE4A
SCHEMBL16827452 0.78 AOC3 (0.47) AOC3PRMT5WDR77NPC1PKM
SCHEMBL16827580 0.78 AOC3 (0.46) AOC3PRMT5WDR77CYP26A1CYP24A1
SCHEMBL16827362 0.78 PDE4A (0.55) AOC3NPC1PKMRAB9APDE4A
SCHEMBL29438613 0.78 PDE4A (0.55) AOC3NPC1PKMRAB9APDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015092634-A1 1,2,3,4-TETRAHYDROISOQUINOLINE COMPOUNDS AND COMPOSITIONS AS SELECTIVE ESTROGEN RECEPTOR ANTAGONISTS AND DEGRADERS NOVARTIS AG (CH) 2015-06-25 — — WO disclosed
Send feedback